M&A
CSL to acquire Novartis’ influenza vaccine unit
27 Oct 2014
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 Oct 2014
US drugmaker Pfizer’s board yesterday authorised a new $11-billion share repurchase plan, which analysts say puts an end to speculations that it would renew its bid for British rival AstraZeneca
Nokia to become Lumia as Microsoft takes control
22 Oct 2014
AbbVie calls off $55-bn acquisition of Shire over US tax rules
22 Oct 2014
AbbVie said the new US tax rules would keep it from gaining access to its overseas cash without having to pay hefty US taxes
Government issues draft order for merger of NSEL with FTIL
21 Oct 2014
National Spot Exchange Ltd and its parent Financial Technologies will be merged to form a new company
Fertilizer giants CF Industries and Yara end merger talks
17 Oct 2014
CF and Yara had late last month said that they were in talks towards a “merger of equals,” and a successful deal would have created a company with an enterprise value of around $30 billion and revenues of around $18.4 billion
TCS to merge subsidiary CMC with itself
17 Oct 2014
TCS' move to merge its subsidiary CMC Ltd with itself will enable the combined entity to jointly bid for bigger deals
Tata Steel in talks to sell European Long Products division
15 Oct 2014
Tata Steel, which expanded to Europe through its $13-billion acquisition of Corus in 2007, said that it has signed an agreement with the Klesch Group for due diligence and negotiations for a potential sale
Birla eyes global assets of Holcim-Lafarge
15 Oct 2014
In order to meet regulatory requirements of global anti-competition authorities Holcim and Lafarge, which announced their proposed merger in April this year, have to divest some assets
AbbVie to reconsider $55-bn Shire deal
15 Oct 2014
AbbVie, the maker of top-selling arthritis drug Humira, plans to buy Shire to lower its US tax burden by moving its tax base to Ireland and to diversify its product line-up
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
